Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Pharmaceutical intermediates >  Heterocyclic compound >  Pyridine compound >  Bromopyridine >  5-Bromo-2-iodo-3-methylpyridine

5-Bromo-2-iodo-3-methylpyridine

Basic information Safety Supplier Related

5-Bromo-2-iodo-3-methylpyridine Basic information

Product Name:
5-Bromo-2-iodo-3-methylpyridine
Synonyms:
  • 5-bromo-2-indo-methylpyridine
  • 5-BROMO-2-IODO-3-METHYLPYRIDINE
  • Pyridine, 5-bromo-2-iodo-3-methyl-
  • 5-Bromo-2-iodo-3-methylpyridine ISO 9001:2015 REACH
  • 2-Iodine-3-Methyl-5-Bromo Pyridine
CAS:
376587-52-9
MF:
C6H5BrIN
MW:
297.92
EINECS:
205-525-8
Product Categories:
  • pharmacetical
Mol File:
376587-52-9.mol
More
Less

5-Bromo-2-iodo-3-methylpyridine Chemical Properties

Boiling point:
279.9±35.0 °C(Predicted)
Density 
2.171±0.06 g/cm3(Predicted)
storage temp. 
under inert gas (nitrogen or Argon) at 2–8 °C
pka
-0.22±0.20(Predicted)
Appearance
Colorless to light yellow Solid-Liquid Mixture
More
Less

Safety Information

HS Code 
2933399990
More
Less

5-Bromo-2-iodo-3-methylpyridine Usage And Synthesis

Uses

5-Bromo-2-iodo-3-methylpyridine can be used as NADPH oxidase inhibitors useful in treatment and prophylaxis of NOX-mediated diseases.

Synthesis

3430-18-0

376587-52-9

2,5-Dibromo-3-methylpyridine (M-12) (5.02 g, 20.0 mmol) was used as a raw material and dissolved in acetonitrile (50 mL). Subsequently, sodium iodide (12.0 g, 80.0 mmol) and acetyl chloride (2.85 mL, 40.0 mmol) were sequentially added to this solution. The reaction mixture was heated and stirred under reflux conditions for 24 hours. Upon completion of the reaction, it was cooled to room temperature, diluted with an appropriate amount of water and the pH was adjusted to 8 with saturated aqueous sodium bicarbonate solution to neutralize the reaction mixture. Extraction was carried out with ethyl acetate, the organic layer was collected and dried over anhydrous sodium sulfate, and the desiccant was removed by filtration. The solvent was removed by concentration under reduced pressure and the resulting residue was purified by silica gel column chromatography (eluent ratio: n-hexane/ethyl acetate=98:2→70:30) to afford the target product 5-bromo-2-iodo-3-methylpyridine (M-13) (5.76 g, 97% yield) as a red oil.

References

[1] Patent: EP3351533, 2018, A1. Location in patent: Paragraph 0321; 0322
[2] Patent: JP2018/145180, 2018, A. Location in patent: Paragraph 0315; 0316; 0317
[3] Patent: WO2014/39484, 2014, A1. Location in patent: Page/Page column 40; 41
[4] Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 2016, vol. 55B, # 9, p. 1117 - 1130
[5] Journal of the American Chemical Society, 2017, vol. 139, # 49, p. 18016 - 18023

5-Bromo-2-iodo-3-methylpyridine Preparation Products And Raw materials

Raw materials

5-Bromo-2-iodo-3-methylpyridineSupplier

Zhuhai Aobokai Biomedical Technology Co., Ltd. Gold
Tel
400-0628126 15697568807;
Email
sales-team@aobchem.com.cn
Capot Chemical Co., Ltd
Tel
+86 (0) 571 85 58 67 18
China Langchem Inc.
Tel
0086-21-58956006
SynAsst Chemical.
Tel
021-60343070
Shanghai Hong-chuang Pharma Tech Co., Ltd.
Tel
18151128828
Email
hc-sales@foxmail.com